Article Text

Download PDFPDF
Case report
Compound heterozygous mutations in KCNJ2 and KCNH2 in a patient with severe Andersen-Tawil syndrome
  1. Margarita E Polyak1,
  2. Anna Shestak1,
  3. Dmitriy Podolyak2 and
  4. Elena Zaklyazminskaya1
  1. 1Laboratory of Medical Genetics, Petrovsky National Research Centre of Surgery, Moscow, Russian Federation
  2. 2Department of Surgical Treatment of Complex Arrhythmias and Pacing, Petrovsky National Research Centre of Surgery, Moscow, Russian Federation
  1. Correspondence to Margarita E Polyak; margaritapolyak{at}gmail.com

Abstract

Andersen-Tawil syndrome (ATS) is a rare channelopathy, sometimes referred to as long QT syndrome type 7. ATS is an autosomal dominant disease predominantly caused by mutations in the KCNJ2 gene. Patients with ATS present with episodes of muscle weakness, arrythmias, including prolonged QT intervals, and various skeletal abnormalities. Unlike other channelopathies, ATS has a relatively mild clinical course and low risk of sudden cardiac death. In this study, we describe a female patient with typical symptoms of ATS with the addition of unusually severe arrhythmias. Extensive DNA testing was performed to find the possible cause of this unique presentation. In addition to a known mutation in KCNJ2, the patient carried a variant in KCNH2. The combination of genetic variants may lead to the severe clinical manifestation of ATS. Additional genetic information allowed accurate genetic counselling to be provided to the patient.

  • arrhythmias
  • genetic screening / counselling
  • cardiovascular system

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors MEP performed the DNA diagnostic, the interpretation of the results and drafted the manuscript. AS performed the DNA diagnostic and the interpretation of the results. DP performed the surgery, prescribed the treatment and monitored the patient during the follow-up period. EZ provided the genetic counselling, interpretation of the results of DNA diagnostic and participated in prescribing the therapy and in the follow-up. All authors contributed to the manuscript preparation and revision.

  • Funding Russian Foundation for Basic Research (20-54-15004).

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.